bothrops alternatus
Recently Published Documents


TOTAL DOCUMENTS

142
(FIVE YEARS 21)

H-INDEX

18
(FIVE YEARS 3)

Author(s):  
Renata Ferreira‐Sgobbi ◽  
Rebeca Machado Figueiredo ◽  
Alana Tercino Frias ◽  
Melina Matthiesen ◽  
Matheus Fitipaldi Batistela ◽  
...  

Toxicon ◽  
2021 ◽  
Vol 202 ◽  
pp. 46-52
Author(s):  
Antônio Rafael Coelho Jorge ◽  
Aline Diogo Marinho ◽  
João Alison de Moraes Silveira ◽  
Francisco Assis Nogueira Junior ◽  
Pedro Everson Alexandre de Aquino ◽  
...  

2021 ◽  
Vol 3 ◽  
Author(s):  
Alba Negrin ◽  
María Alejandra Battocletti ◽  
Carolina Juanena ◽  
Victor Morais

In Uruguay, around 60 cases of snakebite accidents occur every year that need to be treated with specific antivenom. They are caused by two snakes of Bothrops genus: Bothrops alternatus and Bothrops pubescens. Snakebite accidents are mandatory notification events, allowing the acquisition of an accurate registry and a fluent communication with the health care services. The aim of this study is to analyze and report the doses administered to achieve the neutralization of the venom and the adverse reactions caused by snake antivenoms used in Uruguay in 2018, when a change was made in the type of antivenom available. In this year, Uruguay started to use the BIOL® antivenom (lyophilized) and this use coexists with traditional antivenom liquid forms (Vital Brazil and Malbran). The number of patients treated with heterologous BIOL® antivenom were 28 and the ones treated with heterologous solutions Malbran and Vital Brazil antivenoms were 21. The initial dose of BIOL antivenom was 8 vials instead of 4 vials regularly used with the others antivenoms and it achieved the neutralization of most cases (27/28 cases). Early adverse reactions were detected in 4 patients (3 in children) treated with BIOL antivenom and there were no adverse reactions in those treated with Malbran or Vital Brazil antivenoms. Lyophilized antivenom BIOL is being used widely in Uruguay without major complications.


2021 ◽  
Vol 3 (1) ◽  
Author(s):  
Liege Renata Siqueira ◽  
Marcia Helena Martins Panizzutti ◽  
Luís C. Muniz-Pereira ◽  
Roberto Magalhães Pinto

Resultados de exámenes de heces han sido comparados a los obtenidos durante necropsias de serpientesinfectadas con helmintos. Muestras de heces de ejemplares de Bothrops jararaca e B. alternatus fueroninvestigadas y tres animales fueron positivos para huevos durante los exámenes: un caso representandoparásitos autóctonos de serpientes, otro relativo a especies introducidas accidentalmente junto con ratones naturalmente infectados que son ofrecidos como alimentación para las serpientes y otro con la asociación de ambos. Resultados de las necropsias de los mismos ejemplares indican la presencia de los nematodos Ophidascaris travassosi Vaz, 1938, Kalicephalus costatus (Rudolphi, 1819), K. inermis Molin, 1861, Kalicephalus sp. y Acanthorhabdias acanthorhabdias Pereira, 1927. Las especies Bothrops jararaca es un nuevo registro de huésped para Ophidascaris travassosi y Bothrops alternatus para A. acanthorhabdias; los resultados con relación a lesiones macroscópicas inducidas por los nematodos son presentados.


2021 ◽  
Vol 184 ◽  
pp. 56-59
Author(s):  
Igor R. Santos ◽  
Anderson L. Carvalho ◽  
Luan C. Henker ◽  
Marcele B. Bandinelli ◽  
Lívia E. Surita ◽  
...  

2021 ◽  
Vol 41 ◽  
Author(s):  
Warley G. Santos ◽  
Rita C.F. Duarte ◽  
Claudio R.S. Mattoso ◽  
Gabriella M.L. Diamantino ◽  
Ana F.M. Botelho ◽  
...  

ABSTRACT: In Brazil, snakes from the Bothrops genus are responsible for thousands of accidents, and their venoms are mainly composed of proteolytic enzymes. Although the antibothropic serum produced by the Brazilian Institutes is remarkably efficient, more studies are necessary, especially in veterinary medicine. The venom contain enzymes and non-enzymatic proteins that interfere with hemostasis leading to hemorrhage or even thrombosis. Possible treatment associations with known bothropic antivenom were the reason for the development of the present study. The aim of this study was to evaluate hemostasis alterations caused by Bothrops alternatus venom in rabbits followed by treatments with anti-bothropic serum, tranexamic acid and desmopressin. Twenty New Zealand rabbits were distributed into five groups (n=4) that were experimentally envenomed with 150mcg/kg of B. alternatus venom via intramuscular injection and treated as follow: Group 1 (G1) was the positive control and received venom and PBS/BSA; Group 2 (G2) was treated with tranexamic acid; Group 3 (G3) with desmopressin; Group 4 (G4) with tranexamic acid and anti-bothropic serum; and Group 5 (G5) with anti-bothropic serum and desmopressin. Blood samples were collected before venom administration, and one, four, eight and 12 hours after, for Partial activated partial thromboplastin time, Prothrombin Time, Thrombin Time and fibrinogen evaluation. Thrombin generation (TG) test was carried out with a pool of samples from final times (8 and 12h). At the end of 12h, all animals were euthanized and necropsy was conducted. Samples from muscle tissue, heart, lungs and kidney were analyzed. Classic coagulation tests showed no significant differences amongst groups and times. However, TG indicated that the venom causes a hypocoagulability state, which was not reversed by proposed treatments. Histology showed muscle inflammation, hemorrhage and necrosis, as well as hemorrhage in other tissues with no differences amongst groups. B. alternatus envenomation causes hypocoagulability detected by TG assay, but not through classical coagulation tests. The use of tranexamic acid and desmopressin for hemostasis stabilization after inoculation of the venom did not show advantage in coagulation restoration.


2020 ◽  
Vol 34 (1) ◽  
pp. 33-41
Author(s):  
Gisela Paola Bellini ◽  
◽  
Vanesa Arzamendia ◽  
Diana Alberto ◽  
Alejandro Raúl Giraudo

Toxicon ◽  
2020 ◽  
Vol 177 ◽  
pp. S52
Author(s):  
Emilio Angelina ◽  
Soledad Bustillo ◽  
Lucrecia Bogado ◽  
María Emilia García Denegri ◽  
Nelida Peruchena ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document